Denosumab for Male Hemodialysis Patients with Low Bone Mineral Density: A Case-Control Study

Table 5

Parameters of the patients at 12 months.

	Denosumab group	Control group	value
Corrected Ca (mg/dl)	9.1 ± 0.6	9.1 ± 0.4	NS
Phosphate (mg/dl)	5.1 ± 1.4	4.6 ± 0.9	NS
W-PTH (pg/ml)	128 (72 to 191)	140 (76 to 215)	NS
ALP (U/l)	185 ± 59	249 ± 65

The reference range for ALP is from 115 to 359 U/l. Median and interquartile range are shown for whole PTH.